(BBUS) JPMorgan BetaBuilders U.S. - Ratings and Ratios

Exchange: BATS • Country: USA • Currency: USD • Type: Etf • ISIN: US46641Q3992

BBUS: Large-Cap Stocks, Mid-Cap Stocks, Equity Securities

The JPMorgan BetaBuilders U.S. Equity ETF (BATS:BBUS) is designed to track a specific segment of the U.S. equity market. The underlying index is a market capitalization weighted index that focuses on equity securities primarily traded in the United States, with a bias towards large- and mid-cap companies. By targeting 85% of the stocks by market capitalization, the index provides a broad representation of the U.S. equity markets upper and middle tiers.

The funds investment strategy is straightforward, allocating at least 80% of its assets to securities included in the underlying index. This approach ensures that the ETF closely mirrors the performance of the index, providing investors with a diversified portfolio that captures the dynamics of the U.S. large- and mid-cap equity market.

From a technical standpoint, the ETF has demonstrated a positive trend, with its current price of $108.51 exceeding both its 20-day and 50-day simple moving averages (SMA20: $106.59, SMA50: $101.49). The 200-day simple moving average (SMA200: $104.11) also indicates a longer-term uptrend. The average true range (ATR: 1.35 = 1.24%) suggests moderate volatility, which is expected given the ETFs exposure to the equity market. With a 52-week high of $110.66 and a low of $89.63, the ETF has shown resilience and potential for growth.

Considering the funds assets under management (AUM: $4830.32M USD) and its investment strategy, it is likely that the JPMorgan BetaBuilders U.S. Equity ETF will continue to attract investors seeking broad exposure to the U.S. equity market. Based on the technical and fundamental data, a forecast for the ETF could be that it will continue to trade within a moderate range, potentially testing its 52-week high in the near term. If the U.S. equity market maintains its current momentum, the ETF could see its price appreciate, potentially reaching $112-$115 in the coming months.

Additional Sources for BBUS ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

BBUS ETF Overview

Market Cap in USD 4,830m
Category Large Blend
TER 0.02%
IPO / Inception 2019-03-12

BBUS ETF Ratings

Growth Rating 70.8
Fundamental -
Dividend Rating 50.6
Rel. Strength 0.43
Analysts -
Fair Price Momentum 106.37 USD
Fair Price DCF -

BBUS Dividends

Dividend Yield 12m 1.25%
Yield on Cost 5y 2.54%
Annual Growth 5y 5.46%
Payout Consistency 98.9%
Payout Ratio %

BBUS Growth Ratios

Growth Correlation 3m 70.3%
Growth Correlation 12m 44.1%
Growth Correlation 5y 81.4%
CAGR 5y 15.80%
CAGR/Max DD 5y 0.62
Sharpe Ratio 12m 1.44
Alpha 0.45
Beta 1.004
Volatility 11.26%
Current Volume 105.7k
Average Volume 20d 157.2k
What is the price of BBUS shares?
As of June 15, 2025, the stock is trading at USD 108.06 with a total of 105,677 shares traded.
Over the past week, the price has changed by -0.41%, over one month by +1.70%, over three months by +8.89% and over the past year by +11.93%.
Is JPMorgan BetaBuilders U.S. a good stock to buy?
Yes. Based on ValueRay´s Analyses, JPMorgan BetaBuilders U.S. (BATS:BBUS) is currently (June 2025) a good stock to buy. It has a ValueRay Growth Rating of 70.79 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BBUS is around 106.37 USD . This means that BBUS is currently overvalued and has a potential downside of -1.56%.
Is BBUS a buy, sell or hold?
JPMorgan BetaBuilders U.S. has no consensus analysts rating.
What are the forecasts for BBUS share price target?
According to our own proprietary Forecast Model, BBUS JPMorgan BetaBuilders U.S. will be worth about 121.7 in June 2026. The stock is currently trading at 108.06. This means that the stock has a potential upside of +12.6%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 121.7 12.6%